710-1385

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
710 (USA) · Dr. Silva
consented 2012-10-29

AEs

Serious

Dropout signal

–

Adverse events

moderate assessed

Moderate ATRIAL FIBRILLATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-18 (study day 113.0); relationship: NONE

mild assessed

Mild ATRIOVENTRICULAR BLOCK FIRST DEGREE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-11-26 (study day 29.0); relationship: NONE

mild assessed

Mild BLISTER — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-27 (study day 60.0); relationship: POSSIBLE

mild assessed

Mild ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-18 (study day 113.0); relationship: REMOTE

mild assessed

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-18 (study day 51.0); relationship: POSSIBLE

mild assessed

Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-27 (study day 60.0); relationship: POSSIBLE

moderate assessed

Moderate SUPRAVENTRICULAR TACHYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-11-12 (study day 15.0); relationship: NONE

moderate assessed

Moderate SUPRAVENTRICULAR TACHYCARDIA — outcome: RECOVERED/RESOLVED; onset 2012-11-12 (study day 15.0); relationship: NONE

Data queries

No data queries.